Brazilian Universities Advance Rheumatology Research on the Global Stage
Brazilian higher education institutions are playing an increasingly prominent role in international rheumatology research. Universities such as the University of São Paulo (USP), the State University of Campinas (UNICAMP), and the Federal University of Piauí are contributing to major global events in 2026, including EULAR 2026 in London and the PANLAR Congress in Panama City. These platforms allow Brazilian academics to share findings on inflammatory arthritis, autoimmune conditions, and innovative therapies while building international collaborations.
Events like EULAR 2026, held from 3 to 6 June at the ExCeL London, serve as key venues for exchanging scientific and clinical knowledge. Brazilian researchers participate through poster presentations, oral abstracts, and symposia, highlighting work from Brazilian medical schools and research centers. The PANLAR Congress, scheduled for 27–30 April in Panama City, further strengthens regional ties across the Americas, with Brazilian institutions actively involved in discussions on guidelines and interdisciplinary care.
Key International Events Featuring Brazilian Contributions in 2026
The EULAR Congress remains the premier European platform for rheumatology. In 2026, it drew participants from dozens of countries, with Brazilian teams presenting research on disease management and physical activity recommendations. Similarly, the PANLAR Congress emphasizes collaboration among rheumatologists in the Americas, providing opportunities for Brazilian scholars to influence regional standards.
Domestically, the Brazilian Society of Rheumatology (SBR) hosts its own 2026 congress in Curitiba from 2 to 5 September, serving as a bridge between national and international work. These gatherings enable faculty and graduate students from Brazilian universities to refine their research before presenting abroad.
Photo by Matheus Câmara da Silva on Unsplash
Role of Brazilian Higher Education Institutions
Leading Brazilian universities drive much of the country’s rheumatology output. USP and UNICAMP maintain dedicated rheumatology departments that train the next generation of researchers while producing peer-reviewed studies. Faculty from these institutions frequently appear on scientific committees and as speakers at global meetings.
Programs at federal universities across Brazil, including the Federal University of Piauí, support emerging scholars through grants and international exchange opportunities. This infrastructure helps ensure that Brazilian perspectives on conditions such as rheumatoid arthritis and osteoarthritis reach wider audiences.
Challenges and Opportunities for Brazilian Researchers
Funding constraints and infrastructure limitations can hinder full participation in international events. Nevertheless, partnerships with organizations such as the International Osteoporosis Foundation and regional networks help offset costs and expand access. Brazilian universities are increasingly leveraging digital platforms to share findings when travel budgets are limited.
Opportunities arise from growing interest in Latin American research priorities, including the impact of tropical diseases on rheumatic conditions. These unique angles position Brazilian academics as valuable contributors to global conversations.
Photo by Fernando Dantas on Unsplash
Impact on Brazilian Higher Education and Career Pathways
Active involvement in international rheumatology events enhances the reputation of Brazilian universities and opens doors for faculty and students. Participation often leads to co-authored publications, joint grants, and visiting scholar positions abroad.
For PhD candidates and early-career researchers, these experiences build networks that support long-term careers in academia or clinical research. Brazilian institutions are responding by expanding mentorship programs and English-language training to prepare scholars for global stages.
Future Outlook for Brazilian Rheumatology Research
Looking ahead, Brazilian universities are expected to deepen their engagement with events such as ACR Convergence 2026 in Orlando. Continued investment in research infrastructure and international partnerships will be essential to sustaining momentum.
As global health priorities evolve, Brazilian expertise in autoimmune and inflammatory diseases will remain relevant. Universities are positioning themselves to lead collaborative projects that address both regional and worldwide challenges.